Mesa, Ruben A <br/><br/>
Differences in treatment goals and perception of symptom burden between patients with myeloproliferative neoplasms (MPNs) and hematologists/oncologists in the United States: Findings from the MPN Landmark survey.  [electronic resource] 

 -  Cancer  02 2017 
 - 449-458 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1097-0142 
<br/><br/><label>Standard No.: </label>10.1002/cncr.30325  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Female<br/>Humans<br/>Male<br/>Oncologists<br/>Patient Education as Topic<br/>Patients<br/>Polycythemia Vera--drug therapy<br/>Primary Myelofibrosis--drug therapy<br/>Prognosis<br/>Risk Factors<br/>Surveys and Questionnaires<br/>Thrombocythemia, Essential--drug therapy<br/>Thrombosis--drug therapy<br/>United States